Efficacy of Ketorolac 0.4% in Prostaglandin Suppression

Study Identifier
MA-ACU-08-001
CT.gov Identifier
NCT00791323
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Immune & Inflammatory - Other
    • Study Drug
  • Ketorolac 0.4%
  • Lubricating Eye Drop
    • Phase
    Phase 4
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Patients scheduled to undergo phakic IOL implantation
    Exclusion Criteria:
    * History of intraocular surgery in the operative eye

    Protocol Summary

    A pilot study to evaluate the extent of PGE2 inhibition (mean aqueous values) by Ketorolac 0.04% following peripheral iridotomy

    Study Locations

    Location
    Status
    Location
    Houston, Texas, United States
    Status
    Not applicable